Stefan Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stefan Wolf has a total of 198 co-authors. Here are the top co-authors by number of shared publications:
Peter Vajkoczy
10 shared publications- Farid Salih
Neurologische Klinik und Poliklinik, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
6 shared publications Anton Früh
Department of Neurosurgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany; BIH Biomedical Innovation Academy, BIH Charité Junior Digital Clinician Scientist Program, Charitéplatz 1, 10117 Berlin, Germany
4 shared publications- Christoph Rosenthal
Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin (Interdisziplinäre Neurointensivstation), Charite-Universitätsmedizin Berlin
3 shared publications David Wasilewski
Department of Neurosurgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany
3 shared publicationsL. Schürer
Klinikum Bogenhausen
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
Religion and Religiosity in End-of-Life Decisions in Neurocritical Care
Objectives: End-of-life decisions are shaped by diverse biographical, social, and cultural factors. Few studies have systematically examined the impact of religion on end-of-life decisions, and even less data are available on religiosity (i.e., strength of religious faith). The Religion and religiosity in End-of-life deCisiOns in neuroCritIcaL carE (RECONCILE) study aimed to investigate whether religiosity, rather than religion, plays a decisive role in shaping end-of-life decisions. Design: Prospective observational study. Setting: The study was conducted between 2021 and 2024 at two neuro-ICUs at Charité—Universitätsmedizin Berlin. Patients: We prospectively studied patients with acute brain injury and poor neurologic prognosis defined by the absence of regaining decision-making capacity or sufficient autonomy. A total of 100 patients were included. Interventions: None. Measurements: Relatives were consulted to ascertain the patients’ presumed wishes regarding the continuation or withdrawal of life-sustaining intensive care. The 10-item Santa Clara Strength of Religious Faith questionnaire was applied to measure the patient´s religiosity on a scale between 10 and 40 points. We applied the t -test for independent variables to evaluate the influence of religiosity on end-of-life decisions. To adjust for possible confounders like age, sex, nationality, and religion, we calculated a logistic regression as well as an analysis of variance calculation. Main Results: In patients in whom intensive care was continued, the median score was significantly higher compared with patients in whom intensive care was withdrawn (28.1 ± 9.0 vs. 20.5 ± 8.3; p < 0.001; Cohens d = 0.875). This finding was reproduced in each denominational group. Religion, age, and sex showed no significant association with the end-of-life decision behavior. Germans chose withdrawal of therapy significantly more often than non-Germans ( p = 0.01) but also showed significantly lower religiosity scores (21.9 vs. 27.9; p = 0.003). Conclusions: The RECONCILE study demonstrates that religiosity looks more important in influencing end-of-life decisions than religion. Higher levels of religiosity were associated with a preference for more aggressive treatment, even when neurologic prognosis is poor .
- 18 November 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
Open AccessReligion and Religiosity in End-of-Life Decisions in Neurocritical Care
Objectives: End-of-life decisions are shaped by diverse biographical, social, and cultural factors. Few studies have systematically examined the impact of religion on end-of-life decisions, and even less data are available on religiosity (i.e., strength of religious faith). The Religion and religiosity in End-of-life deCisiOns in neuroCritIcaL carE (RECONCILE) study aimed to investigate whether religiosity, rather than religion, plays a decisive role in shaping end-of-life decisions. Design: Prospective observational study. Setting: The study was conducted between 2021 and 2024 at two neuro-ICUs at Charité—Universitätsmedizin Berlin. Patients: We prospectively studied patients with acute brain injury and poor neurologic prognosis defined by the absence of regaining decision-making capacity or sufficient autonomy. A total of 100 patients were included. Interventions: None. Measurements: Relatives were consulted to ascertain the patients’ presumed wishes regarding the continuation or withdrawal of life-sustaining intensive care. The 10-item Santa Clara Strength of Religious Faith questionnaire was applied to measure the patient´s religiosity on a scale between 10 and 40 points. We applied the t -test for independent variables to evaluate the influence of religiosity on end-of-life decisions. To adjust for possible confounders like age, sex, nationality, and religion, we calculated a logistic regression as well as an analysis of variance calculation. Main Results: In patients in whom intensive care was continued, the median score was significantly higher compared with patients in whom intensive care was withdrawn (28.1 ± 9.0 vs. 20.5 ± 8.3; p < 0.001; Cohens d = 0.875). This finding was reproduced in each denominational group. Religion, age, and sex showed no significant association with the end-of-life decision behavior. Germans chose withdrawal of therapy significantly more often than non-Germans ( p = 0.01) but also showed significantly lower religiosity scores (21.9 vs. 27.9; p = 0.003). Conclusions: The RECONCILE study demonstrates that religiosity looks more important in influencing end-of-life decisions than religion. Higher levels of religiosity were associated with a preference for more aggressive treatment, even when neurologic prognosis is poor .
- Open Access
- 7 August 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Admission laboratory parameters for early risk stratification after aneurysmal subarachnoid hemorrhage: a machine learning analysis of real-world data
- 7 August 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Open AccessAdmission laboratory parameters for early risk stratification after aneurysmal subarachnoid hemorrhage: a machine learning analysis of real-world data
- Open Access
- 25 February 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (5) , 1110-1113
Going with the flow: lumbar cerebrospinal fluid drainage after aneurysmal subarachnoid hemorrhage: indications, safety, and practical considerations
- 25 February 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (5) , 1110-1113
Open AccessGoing with the flow: lumbar cerebrospinal fluid drainage after aneurysmal subarachnoid hemorrhage: indications, safety, and practical considerations
- Open Access
- 6 May 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155104
Evaluating extreme temperature values and patient outcomes in aneurysmal subarachnoid hemorrhage: Post-hoc insights from the Earlydrain trial
- 6 May 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155104
Open AccessEvaluating extreme temperature values and patient outcomes in aneurysmal subarachnoid hemorrhage: Post-hoc insights from the Earlydrain trial
- Open Access
- 11 June 2024
- Published by Elsevier in World Neurosurgery
- Vol. 189, 127-131
Bedside Technique for the Implantation of Licox Brain Tissue Oxygen Probes in Occipital Regions: A Technical Note
- 11 June 2024
- Published by Elsevier in World Neurosurgery
- Vol. 189, 127-131
Open AccessBedside Technique for the Implantation of Licox Brain Tissue Oxygen Probes in Occipital Regions: A Technical Note
- Open Access
- 21 May 2024
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (9) , 1391-1401
Association of Fluid Balance and Hemoglobin Decline With Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage*
OBJECTIVES: To explore the relationship between fluid balance and hemoglobin decline with secondary infarctions and neurologic outcome in aneurysmal subarachnoid hemorrhage (aSAH) patients. DESIGN: Secondary analysis of the Earlydrain trial, a prospective randomized controlled study investigating prophylactic lumbar drain use in aSAH patients. SETTING: Patients with aSAH treated in ICUs at 19 tertiary hospitals in Germany, Switzerland, and Canada. PATIENTS: From January 2011 to January 2016, 287 patients were enrolled in the Earlydrain trial. Only files with complete information on both daily hemoglobin and balance values were used, leaving 237 patients for analysis. INTERVENTIONS: Investigation of fluid balance management and hemoglobin levels during the initial 8 days post-aSAH to establish thresholds for unfavorable outcomes and assess their impact on secondary infarctions and 6-month neurologic outcome on the modified Rankin Scale (mRS). MEASUREMENTS AND MAIN RESULTS: Patients with unfavorable outcome after 6 months (mRS > 2) showed greater hemoglobin decline and increased cumulative fluid balance. A significant inverse relationship existed between fluid balance and hemoglobin decline. Thresholds for unfavorable outcome were 10.4 g/dL hemoglobin and 4894 mL cumulative fluid balance in the first 8 days. In multivariable analysis, fluid balance, but not fluid intake, remained significantly associated with unfavorable outcome, while the influence of hemoglobin lessened. Fluid balance but not hemoglobin related to secondary infarctions, with the effect being significant after inverse probability of treatment weighting. Transfusion was associated with unfavorable outcomes. CONCLUSIONS: Increased fluid balance influences hemoglobin decline through hemodilution. Fluid overload, rather than a slight decrease in hemoglobin levels, appears to be the primary factor contributing to poor outcomes in aSAH patients. The results suggest aiming for euvolemia and that a modest hemoglobin decline may be tolerated. It may be advisable to adopt a restrictive approach to transfusions, as they can potentially have a negative effect on outcome.
- 21 May 2024
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (9) , 1391-1401
Open AccessAssociation of Fluid Balance and Hemoglobin Decline With Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage*
OBJECTIVES: To explore the relationship between fluid balance and hemoglobin decline with secondary infarctions and neurologic outcome in aneurysmal subarachnoid hemorrhage (aSAH) patients. DESIGN: Secondary analysis of the Earlydrain trial, a prospective randomized controlled study investigating prophylactic lumbar drain use in aSAH patients. SETTING: Patients with aSAH treated in ICUs at 19 tertiary hospitals in Germany, Switzerland, and Canada. PATIENTS: From January 2011 to January 2016, 287 patients were enrolled in the Earlydrain trial. Only files with complete information on both daily hemoglobin and balance values were used, leaving 237 patients for analysis. INTERVENTIONS: Investigation of fluid balance management and hemoglobin levels during the initial 8 days post-aSAH to establish thresholds for unfavorable outcomes and assess their impact on secondary infarctions and 6-month neurologic outcome on the modified Rankin Scale (mRS). MEASUREMENTS AND MAIN RESULTS: Patients with unfavorable outcome after 6 months (mRS > 2) showed greater hemoglobin decline and increased cumulative fluid balance. A significant inverse relationship existed between fluid balance and hemoglobin decline. Thresholds for unfavorable outcome were 10.4 g/dL hemoglobin and 4894 mL cumulative fluid balance in the first 8 days. In multivariable analysis, fluid balance, but not fluid intake, remained significantly associated with unfavorable outcome, while the influence of hemoglobin lessened. Fluid balance but not hemoglobin related to secondary infarctions, with the effect being significant after inverse probability of treatment weighting. Transfusion was associated with unfavorable outcomes. CONCLUSIONS: Increased fluid balance influences hemoglobin decline through hemodilution. Fluid overload, rather than a slight decrease in hemoglobin levels, appears to be the primary factor contributing to poor outcomes in aSAH patients. The results suggest aiming for euvolemia and that a modest hemoglobin decline may be tolerated. It may be advisable to adopt a restrictive approach to transfusions, as they can potentially have a negative effect on outcome.
- Open Access
- 15 April 2024
- Published by Springer Nature in Neurocritical Care
- Vol. 41 (2) , 619-631
Analysis of Cerebral Spinal Fluid Drainage and Intracranial Pressure Peaks in Patients with Subarachnoid Hemorrhage
Background: After aneurysmal subarachnoid hemorrhage (aSAH), elevated intracranial pressure (ICP) due to disrupted cerebrospinal fluid (CSF) dynamics is a critical concern. An external ventricular drainage (EVD) is commonly employed for management; however, optimal strategies remain debated. The randomized controlled Earlydrain trial showed that an additional prophylactic lumbar drainage (LD) after aneurysm treatment improves neurological outcome. We performed a post hoc investigation on the impact of drainage volumes and critical ICP values on patient outcomes after aSAH. Methods: Using raw patient data from Earlydrain, we analyzed CSF drainage amounts and ICP measurements in the first 8 days after aSAH. Outcomes were the occurrence of secondary infarctions and the score on the modified Rankin scale after 6 months, dichotomized in values of 0–2 as favorable and 3–6 as unfavorable. Repeated measurements were considered with generalized estimation equations. Results: Earlydrain recruited 287 patients, of whom 221 received an EVD and 140 received an LD. Higher EVD volumes showed a trend to more secondary infarctions (p = 0.09), whereas higher LD volumes were associated with less secondary infarctions (p = 0.009). The mean total CSF drainage was 1052 ± 659 mL and did not differ concerning infarction and neurological outcome. Maximum ICP values were higher in patients with poor outcomes but not related to drainage volumes via EVD. After adjustment for aSAH severity and total CSF drainage, higher LD volume was linked to favorable outcome (per 100 mL: odds ratio 0.61 (95% confidence interval 0.39–0.95), p = 0.03), whereas higher EVD amounts were associated with unfavorable outcome (per 100 mL: odds ratio 1.63 (95% confidence interval 1.05–2.54), p = 0.03). Conclusions: Findings indicate that effects of CSF drainage via EVD and LD differ. Higher amounts and higher proportions of LD volumes were associated with better outcomes, suggesting a potential quantity-dependent protective effect. Optimizing LD volume and mitigating ICP spikes may be a strategy to improve patient outcomes after aSAH. Clinical trial registration: ClinicalTrials.gov identifier: NCT01258257.
- 15 April 2024
- Published by Springer Nature in Neurocritical Care
- Vol. 41 (2) , 619-631
Open AccessAnalysis of Cerebral Spinal Fluid Drainage and Intracranial Pressure Peaks in Patients with Subarachnoid Hemorrhage
Background: After aneurysmal subarachnoid hemorrhage (aSAH), elevated intracranial pressure (ICP) due to disrupted cerebrospinal fluid (CSF) dynamics is a critical concern. An external ventricular drainage (EVD) is commonly employed for management; however, optimal strategies remain debated. The randomized controlled Earlydrain trial showed that an additional prophylactic lumbar drainage (LD) after aneurysm treatment improves neurological outcome. We performed a post hoc investigation on the impact of drainage volumes and critical ICP values on patient outcomes after aSAH. Methods: Using raw patient data from Earlydrain, we analyzed CSF drainage amounts and ICP measurements in the first 8 days after aSAH. Outcomes were the occurrence of secondary infarctions and the score on the modified Rankin scale after 6 months, dichotomized in values of 0–2 as favorable and 3–6 as unfavorable. Repeated measurements were considered with generalized estimation equations. Results: Earlydrain recruited 287 patients, of whom 221 received an EVD and 140 received an LD. Higher EVD volumes showed a trend to more secondary infarctions (p = 0.09), whereas higher LD volumes were associated with less secondary infarctions (p = 0.009). The mean total CSF drainage was 1052 ± 659 mL and did not differ concerning infarction and neurological outcome. Maximum ICP values were higher in patients with poor outcomes but not related to drainage volumes via EVD. After adjustment for aSAH severity and total CSF drainage, higher LD volume was linked to favorable outcome (per 100 mL: odds ratio 0.61 (95% confidence interval 0.39–0.95), p = 0.03), whereas higher EVD amounts were associated with unfavorable outcome (per 100 mL: odds ratio 1.63 (95% confidence interval 1.05–2.54), p = 0.03). Conclusions: Findings indicate that effects of CSF drainage via EVD and LD differ. Higher amounts and higher proportions of LD volumes were associated with better outcomes, suggesting a potential quantity-dependent protective effect. Optimizing LD volume and mitigating ICP spikes may be a strategy to improve patient outcomes after aSAH. Clinical trial registration: ClinicalTrials.gov identifier: NCT01258257.
- Open Access
- 29 February 2024
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (1) , 133-146
Red Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies
Subarachnoid haemorrhage (SAH) is a subtype of stroke that predominantly impacts younger individuals. It is associated with high mortality rates and can cause long-term disabilities. This review examines the contribution of the initial blood load and the dynamics of clot clearance to the pathophysiology of SAH and the risk of adverse outcomes. These outcomes include hydrocephalus and delayed cerebral ischaemia (DCI), with a particular focus on the impact of blood located in the cisternal spaces, as opposed to ventricular blood, in the development of DCI. The literature described underscores the prognostic value of haematoma characteristics, such as volume, density, and anatomical location. The limitations of traditional radiographic grading systems are discussed, compared with the more accurate volumetric quantification techniques for predicting patient prognosis. Further, the significance of red blood cells (RBCs) and their breakdown products in secondary brain injury after SAH is explored. The review presents novel interventions designed to accelerate clot clearance or mitigate the effects of toxic byproducts released from erythrolysis in the cerebrospinal fluid following SAH. In conclusion, this review offers deeper insights into the complex dynamics of SAH and discusses the potential pathways available for advancing its management.
- 29 February 2024
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (1) , 133-146
Open AccessRed Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies
Subarachnoid haemorrhage (SAH) is a subtype of stroke that predominantly impacts younger individuals. It is associated with high mortality rates and can cause long-term disabilities. This review examines the contribution of the initial blood load and the dynamics of clot clearance to the pathophysiology of SAH and the risk of adverse outcomes. These outcomes include hydrocephalus and delayed cerebral ischaemia (DCI), with a particular focus on the impact of blood located in the cisternal spaces, as opposed to ventricular blood, in the development of DCI. The literature described underscores the prognostic value of haematoma characteristics, such as volume, density, and anatomical location. The limitations of traditional radiographic grading systems are discussed, compared with the more accurate volumetric quantification techniques for predicting patient prognosis. Further, the significance of red blood cells (RBCs) and their breakdown products in secondary brain injury after SAH is explored. The review presents novel interventions designed to accelerate clot clearance or mitigate the effects of toxic byproducts released from erythrolysis in the cerebrospinal fluid following SAH. In conclusion, this review offers deeper insights into the complex dynamics of SAH and discusses the potential pathways available for advancing its management.
- Open Access
- 8 February 2024
- Published by Elsevier in World Neurosurgery
- Vol. 184, e720-e730
Early Complications and Outcome After Treatment of Ruptured Aneurysms in Patients with Subarachnoid Hemorrhage–A Post Hoc Analysis of the EARLYDRAIN Trial
- 8 February 2024
- Published by Elsevier in World Neurosurgery
- Vol. 184, e720-e730
Open AccessEarly Complications and Outcome After Treatment of Ruptured Aneurysms in Patients with Subarachnoid Hemorrhage–A Post Hoc Analysis of the EARLYDRAIN Trial